Fossil Remedies
OCTOBER 23, 2019
STEPS TO START A PHARMACEUTICAL DISTRIBUTION COMPANY. When the pharma secto r is touching new heights year after year, it is a great idea to take the business benefits from it. Due to technological and scientific advances, pharmaceutical innovations are happening every second day. It means the opportunities are more than ever, especially if you are an enthusiastic entrepreneur.
The Nontraditional Pharmacist
OCTOBER 14, 2019
Kim Tran’s participation with TNP shows how taking advantage of a networking opportunity can lead to making great connections. You never know where a simple conversation will take you! Name : Kim Tran. Position: Pharmacy Student at Oregon State University. Interview Summary. Kim [00:00:00] Hi everyone and this is Kim Tran. I am a PharmD, MBA candidate at Oregon State University and you are listening to The Nontraditional Pharmacist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Digital Apothecary
OCTOBER 4, 2019
Why Digital Health is Key for Pharmacy. And our current pursuits are just not enough. If you have been following my work, you are well aware of my passion and dedication towards getting pharmacists aware of digital health and its implications for future health practice. However, in all honesty, I think I have seen little takeoff amongst the profession by and large, and it has led me to question why that is, so let me break down my current thought process.
pharmaphorum
OCTOBER 30, 2019
Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies). Payers are in a difficult spot regarding the cost and management of these regimens. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying tr
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Med Ed 101
OCTOBER 30, 2019
In this case scenario below, I discuss the mirabegron tamoxifen interaction and how it can impact patient safety. KS is a 61-year-old female who presents with worsening urinary frequency. She has been diagnosed with overactive bladder and place on oxybutynin. She was taking 5 mg daily and states that the dry mouth from the medication […]. The post Mirabegron Tamoxifen Interaction – Case Scenario appeared first on Med Ed 101.
Med Ed 101
OCTOBER 23, 2019
When the NOACs (sometimes referred to as DOACs) first came out they were heavily promoted as having fewer drug interactions compared to warfarin. This is true, but please remember that “fewer drug interactions” doesn’t mean “no drug interactions”! Here’s a scenario of the carbamazepine apixaban interaction and some potential strategies to manage it.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Med Ed 101
OCTOBER 16, 2019
As you are reviewing a medication list, it can be easy to overlook supplements. The next time you review a medication list and you see sodium chloride supplements on the list, I want you to think of this post. If you have a patient who needs more sodium, they likely have a problem maintaining a […]. The post Sodium Chloride Supplements – Don’t Overlook Them appeared first on Med Ed 101.
Med Ed 101
OCTOBER 13, 2019
Our 2020 BCPS Study Material has now been updated and is ready for release!! We’ve reviewed and followed the BCPS content outline closely! If you are considering taking the BCPS exam in the Spring OR Fall of 2020 next year, we’ve done quite a bit of updating! (See below) Here’s some of the feedback we’ve […]. The post 2020 BCPS Study Material Is Ready to Roll!
Med Ed 101
OCTOBER 9, 2019
We’ve been creating and updating content this fall and getting ready for 2020! Updates will be coming soon as they do every year at this time. BCMTMS (discount ends tomorrow) was just done and BCPS, BCACP, BCGP will be done within the next few weeks! As test time approaches, one of the most frequent questions […]. The post Do I Need to Memorize Labs for the BCPS Exam?
Med Ed 101
OCTOBER 6, 2019
It is that time of year when we work on updates for our study material and release our All Access Pass for 2020 participants! The BCMTMS certification is something that many pharmacists are pursuing to help improve their resume and their clinical skillset. We are absolutely HONORED to have our study materials mentioned on the […]. The post 2020 BCMTMS Study Material appeared first on Med Ed 101.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Med Ed 101
OCTOBER 2, 2019
A 68-year-old male presents to your care with chronic back pain. He is taking ketorolac and states that NSAIDs are the mainstay of pain relief. He won’t take opioids due to a family history of addiction. Acetaminophen and other medications he has tried in the past just didn’t do much. He was recently told that […]. The post Strategies to Reduce GI Risk With NSAIDs appeared first on Med Ed 101.
Expert insights. Personalized for you.
67 
Let's personalize your content